Empfehlungen zur peri-prozeduralen Thrombozytenaggregationshemmung

Literatur

• 1 Allard R H, Baart J A. Antithrombotic Therapy and Dental Surgery with Bleeding.  Ned Tijdschr Tandheelkd. 2004;  111 482-485
• 2 Diener H C. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH).  Lancet. 2004;  364 331-337
• 3 Guyatt G, Schunemann H. Grades of Recommendation for Antithrombotic Agents.  Chest. 2001;  119 3-7S
• 4 Hui A J, Wong R M. Risk of Colonoscopic Polypectomy Bleeding with Anticoagulants and Antiplatelet Agents.  Gastrointest Endosc. 2004;  59 44-48
• 5 Kapetanakis E I, Medlam D A. Clopidogrel Administration Prior to Coronary Artery Bypass Grafting Surgery: The Cardiologist’s Panacea or The Surgeon’s Headache?.  Eur Heart J. 2005;  26 576-583
• 6 Kearon C, Hirsh J. Anticoagulation and Elective Surgery.  N Engl J Med. 1997;  336 1506-1511
• 7 Leitlinien der DGAI . Rückenmarknahe Regionalanästhesien und Thromboembolieprophylaxe/Antikoagulation.  Anästhesiologie & Intensivmedizin. 2003;  44 218-230
• 8 Ong A T, McFadden E P. Late Angiographic Stent Thrombosis (LAST) Events with Drug-eluting Stents.  J Am Coll Cardiol. 2005;  45 2088-2092
• 9 Schepke M, Pötzsch B. Leitlinien der DGVS, Endoskopie bei Patienten mit erhöhtem Blutungsrisiko,. www.DGVS.de/Leitlinien/1.3.Blutungsrisiko.pdf
• 10 Serebruany V L, Steinhubl S R. Variability in Platelet Responsiveness to Clopidogrel Among 544 Individuals.  J Am Coll Cardiol. 2005;  45 246-251
• 11 Steinhubl S R, Berger P B. Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention.  JAMA. 2002;  288 2411-2420
• 12 Weir N U, Demchuk A M. Stroke Prevention: MATCHing Therapy to The Patient with TIA.  Postgrad Med. 2005;  117 26-30
• 13 Wilson S H, Fasseas P. Clinical Outcome of Patients Undergoing Non-cardiac Surgery in The Two Months Following Coronary Stenting.  J Am Coll Cardiol. 2003;  42 234-240